Ingevity Corporation
NGVT
$46.91
-$0.45-0.95%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.41B | 1.48B | 1.55B | 1.64B | 1.69B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.41B | 1.48B | 1.55B | 1.64B | 1.69B |
| Cost of Revenue | 945.40M | 1.05B | 1.12B | 1.18B | 1.20B |
| Gross Profit | 461.00M | 432.10M | 431.20M | 461.00M | 491.70M |
| SG&A Expenses | 166.60M | 171.00M | 172.30M | 182.60M | 184.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.14B | 1.25B | 1.32B | 1.39B | 1.42B |
| Operating Income | 266.30M | 233.10M | 229.80M | 248.60M | 275.90M |
| Income Before Tax | -535.60M | -698.40M | -528.40M | -146.10M | -10.10M |
| Income Tax Expenses | -105.30M | -134.70M | -97.10M | -34.00M | -4.70M |
| Earnings from Continuing Operations | -430.30 | -563.70 | -431.30 | -112.10 | -5.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -430.30M | -563.70M | -431.30M | -112.10M | -5.40M |
| EBIT | 266.30M | 233.10M | 229.80M | 248.60M | 275.90M |
| EBITDA | 374.60M | 339.40M | 348.00M | 369.90M | 398.70M |
| EPS Basic | -11.84 | -15.53 | -11.88 | -3.10 | -0.19 |
| Normalized Basic EPS | 2.15 | 1.64 | 1.56 | 2.26 | 3.18 |
| EPS Diluted | -11.85 | -15.54 | -11.90 | -3.12 | -0.22 |
| Normalized Diluted EPS | 2.15 | 1.64 | 1.56 | 2.25 | 3.16 |
| Average Basic Shares Outstanding | 145.24M | 145.14M | 145.02M | 145.06M | 145.97M |
| Average Diluted Shares Outstanding | 145.54M | 145.14M | 145.19M | 145.45M | 146.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
